Coya Therapeutics
COYA
36 hedge funds and large institutions have $27.1M invested in Coya Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
9% more funds holding
Funds holding: 33 → 36 (+3)
5% more capital invested
Capital invested by funds: $25.8M → $27.1M (+$1.32M)
1.62% more ownership
Funds ownership: 26.81% → 28.44% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$620K |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$608K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$254K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$135K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$134K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$153K |
| 2 |
AI
Atom Investors
Austin,
Texas
|
-$115K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$102K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$42.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24.8K |
COYA Hedge Fund Activity: Q3 2025 in Review
36 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q3 2025, worth a combined $27.1M — up 5.1% from $25.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new COYA positions and 4 closed out — a net gain of 3 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Dauntless Investment Group, adding an estimated $620K. The largest seller was Jane Street, exiting entirely with an estimated $153K sold.
- 36 institutional investors held Coya Therapeutics (COYA) as of Q3 2025, up from 33 in Q2 2025.
- Funds reported $27.1M of Coya Therapeutics stock for Q3 2025, up 5.1% quarter-over-quarter.
- 7 funds opened new Coya Therapeutics positions in Q3 2025 and 4 closed out, a net change of +3 holders.
- The largest Coya Therapeutics buyer in Q3 2025 was Dauntless Investment Group, an estimated $620K added.
- The largest Coya Therapeutics seller in Q3 2025 was Jane Street, an estimated $153K sold.
Based on aggregated 13F filings for Q3 2025.